drd2026@fbu.edu.tr

0216 910 19 07

  • • Advanced therapy medicinal products
  • • Aging & longevity
  • • Analytical method validation
  • • Artificial intelligence
  • • Bioanalysis
  • • Bioavailability/ bioequivalence
  • • Biochemistry
  • • Bioengineering
  • • Bioinorganic chemistry
  • • Biomarkers
  • • Biopharmaceutics
  • • Biosensors
  • • Biosimilar medicines
  • • Biotechnology
  • • Biowaivers
  • • Clinical pharmacy
  • • Cosmetics
  • • DNA separating/sequencing
  • • Drug analysis
  • • Drug degradation
  • • Drug cytotoxicity
  • • Drug delivery
  • • Drug design/molecular modelling
  • • Drug licensing and regulations
  • • Drug manufacturing and product quality
  • • Drug metabolism
  • • Drug regulations
  • • Drug resistance
  • • Drug synthesis
  • • Drug targeting
  • • Drug-drug interactions
  • • Drug-receptor interactions
  • • Ethics
  • • Fluxomics
  • • Food supplements
  • • Food-drug synergies
  • • Forensic pharmacy
  • • Generic medicines
  • • Genomics
  • • Geriatric pharmacy
  • • Herbal medicines
  • • Industrial pharmacy
  • • Industrial research management
  • • Machine learning
  • • Medical devices
  • • Metabolomics
  • • Molecular mechanisms of diseases
  • • Molecular pharmacology
  • • Multidimensional separation
  • • Nanomedicine and nanomaterials
  • • Natural products and medicinal plants
  • • Neuropeptides and neurotoxicity
  • • Neuropharmacology
  • • Organic/inorganic chemistry
  • • Orphan drugs and rare diseases
  • • Oxidative stress
  • • Patents
  • • Patient safety
  • • Peptides as drugs
  • • Peptide-target interaction
  • • Pharmaceutical microbiology
  • • Pharmacoeconomy
  • • Pharmacogenetics and pharmacogenomics
  • • Pharmacokinetics
  • • Pharmacotherapy
  • • Pharmacovigilance
  • • Pharmacy management
  • • Phytotherapy
  • • Precision/personalized medicine
  • • Preclinical/clinical trials
  • • Pre-formulation and formulation design
  • • Proteomics and peptidomics
  • • QbD (Quality by Design) and PAT (Process Analytical Technology)
  • • Quality control and quality assurance
  • • Quorum-sensing inhibitors
  • • Radiopharmaceuticals
  • • Research and development strategies
  • • Space pharmacy
  • • Sports pharmacy
  • • Stereochemistry in drug action
  • • Structure-activity relationships
  • • Therapeutic enzymes, activators and inhibitors
  • • Toxicity screening in drug development
  • • Translational drug research
  • • Vaccine research